IVRN (Innoveren Scientific) Cyclically Adjusted Book per Share: $225.03 (As of Sep. 2023)


IVRN Innoveren Scientific Inc IVRN
16 GF Score
Price $0.00
View Full Analysis

What is Innoveren Scientific Cyclically Adjusted Book per Share?

Innoveren Scientific IVRN 16 Cyclically Adjusted Book per Share is $225.03 as of Sep. 2023. GuruFocus rates IVRN with a GF Score™ of 16/100.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Innoveren Scientific's adjusted book value per share for the three months ended in Sep. 2023 was $-15.912. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $225.03 for the trailing ten years ended in Sep. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

As of today (2026-06-28), Innoveren Scientific's current stock price is $0.0007. Innoveren Scientific's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was $225.03. Innoveren Scientific's Cyclically Adjusted PB Ratio of today is 0.00.


Innoveren Scientific  (OTCPK:IVRN) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Innoveren Scientific's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.0007/225.03
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Innoveren Scientific Cyclically Adjusted Book per Share Related Terms


Innoveren Scientific Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Innoveren Scientific's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific Cyclically Adjusted Book per Share Chart

Innoveren Scientific Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Innoveren Scientific Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 225.03

IVRN vs GNCA, ISCO, FNAM: Cyclically Adjusted Book per Share Comparison

For the Biotechnology subindustry, Innoveren Scientific's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Innoveren Scientific Cyclically Adjusted PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Innoveren Scientific's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Innoveren Scientific's Cyclically Adjusted PB Ratio falls into.


IVRN
16GF Score
Innoveren Scientific Inc IVRN
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Innoveren Scientific Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Innoveren Scientific's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=-15.912/307.7890*307.7890
=-15.912

Current CPI (Sep. 2023) = 307.7890.

Innoveren Scientific Quarterly Data

Book Value per Share CPI Adj_Book
201312 286.222 233.049 378.015
201403 0.000 236.293 0.000
201406 159.667 238.343 206.189
201409 97.778 238.031 126.433
201412 722.889 234.812 947.555
201503 1,624.444 236.119 2,117.517
201506 1,164.818 238.638 1,502.352
201509 1,040.182 237.945 1,345.507
201512 911.182 236.525 1,185.717
201603 796.333 238.132 1,029.272
201606 100.923 241.018 128.882
201609 98.214 241.428 125.210
201612 -29.867 241.432 -38.076
201703 111.471 243.801 140.728
201706 44.111 244.955 55.426
201709 95.571 246.819 119.179
201712 33.952 246.524 42.390
201803 -7.348 249.554 -9.063
201806 -9.000 251.989 -10.993
201809 -58.478 252.439 -71.300
201812 -79.880 251.233 -97.862
201903 101.287 254.202 122.639
201906 124.485 256.143 149.585
201909 100.313 256.759 120.250
201912 -90.900 256.974 -108.875
202003 -115.980 258.115 -138.300
202006 -176.760 257.797 -211.037
202009 2.574 260.280 3.044
202012 -12.488 260.474 -14.756
202103 -19.073 264.877 -22.163
202106 -26.214 271.696 -29.696
202109 -28.336 274.310 -31.794
202112 -31.488 278.802 -34.762
202203 -18.450 287.504 -19.752
202206 -27.525 296.311 -28.591
202209 -17.967 296.808 -18.632
202212 -15.826 296.797 -16.412
202303 -18.737 301.836 -19.107
202306 -16.451 305.109 -16.596
202309 -15.912 307.789 -15.912

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of $225.03 mean?
Innoveren Scientific (IVRN) has a Cyclically Adjusted Book per Share of $225.03 as of Sep. 2023. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Innoveren Scientific and its competitors.
Is Innoveren Scientific's Cyclically Adjusted Book per Share too high?
Innoveren Scientific's current Cyclically Adjusted Book per Share is $225.03. Overall, Innoveren Scientific has a GF Score™ of 16/100, reflecting its overall financial health beyond just this single metric.
How does Innoveren Scientific's Cyclically Adjusted Book per Share compare to GNCA and ISCO?
Innoveren Scientific's Cyclically Adjusted Book per Share of $225.03 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Biotechnology company?
A good Cyclically Adjusted Book per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Innoveren Scientific and its competitors. Innoveren Scientific's current Cyclically Adjusted Book per Share is $225.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innoveren Scientific stock overvalued right now?
Innoveren Scientific (IVRN) has a current Cyclically Adjusted Book per Share of $225.03. The current Cyclically Adjusted Book per Share is $225.03. Innoveren Scientific's overall GF Score™ is 16/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Innoveren Scientific (IVRN), the current Cyclically Adjusted Book per Share is $225.03 as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innoveren Scientific Business Description

Address 2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607
Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.
16GF Score

Get the complete analysis for IVRN

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price